Geno- and phenotyping currently represent the main biological pillars for personalized medicine, particularly with regard to the prescription of psychotropic medications.. Nonetheless we are missing data regarding the usefulness of combining TDM with pharmacogenetics in patients treated with long-acting injectable antipsychotics (LAIs).
No takes yet. Share an insight, caveat, or question.
Conca et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: